MULTIPHARMA GROUP: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
MULTIPHARMA GROUP
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€242,114
2024 · -€60,057-€182,057
Equity
€164.7m
2024 · €131.2m+€33.5m
Cash
€250,731
2024 · €87,566+€163,165
Balance sheet total
€166.0m
2024 · €131.8m+€34.3m
Largest movements
Assets
- Financial fixed assets +€34.0m
up €34.0m (+25.9%), from €131.2m to €165.2m
of which Affiliated companies: +€34.0m
Equity and liabilities
- Contributions +€35.0m
up €35.0m (+414.4%), from €8.4m to €43.4m
Income statement
No income-statement line moved by more than 1% of the activity.
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
-€60,057
Other operating charges
-€3,749
Other operating items
-€180,617
Financial income
+€9,366
Financial charges
+€90
Taxes
-€7,147
Result 2025
-€242,114
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€466,166
Investment
-€34.0m
Financing
+€33.7m
Cash 2024
€87,566
From operations (derived)
+€466,166
Net result for the year
-€242,114
Smaller working-capital items
-€88,026
Other debts
+€796,306
Investment (derived)
-€34.0m
Investment in fixed assets (net)
-€34.0m
Financing
+€33.7m
Contributions, distributions and other
+€33.7m
Cash 2025
€250,731
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €131,767,159 | €166,043,185 | +€34.3m | +26.0% |
| Fixed assets | 21/28 | €131,211,147 | €165,211,147 | +€34.0m | +25.9% |
| Financial fixed assets | 28 | €131,211,147 | €165,211,147 | +€34.0m | +25.9% |
| Affiliated companies | 280/1 | €131,208,668 | €165,208,668 | +€34.0m | +25.9% |
| Participating interests | 280 | €126,208,668 | €161,208,668 | +€35.0m | +27.7% |
| Amounts receivable | 281 | €5,000,000 | €4,000,000 | -€1.0m | -20.0% |
| Other financial fixed assets | 284/8 | €2,479 | €2,479 | = | 0.0% |
| Shares | 284 | €2,479 | €2,479 | = | 0.0% |
| Current assets | 29/58 | €556,012 | €832,038 | +€276,026 | +49.6% |
| Amounts receivable within one year | 40/41 | €360,896 | €417,040 | +€56,144 | +15.6% |
| Other amounts receivable | 41 | €360,896 | €417,040 | +€56,144 | +15.6% |
| Current investments | 50/53 | €5,718 | €5,718 | = | 0.0% |
| Other investments | 51/53 | €5,718 | €5,718 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €87,566 | €250,731 | +€163,165 | +186.3% |
| Deferred charges and accrued income | 490/1 | €101,832 | €158,549 | +€56,717 | +55.7% |
| Total equity and liabilities | 10/49 | €131,767,159 | €166,043,185 | +€34.3m | +26.0% |
| Equity | 10/15 | €131,244,162 | €164,699,047 | +€33.5m | +25.5% |
| Contributions | 10/11 | €8,445,000 | €43,445,000 | +€35.0m | +414.4% |
| Revaluation surpluses | 12 | €1,020,924 | €1,020,924 | = | 0.0% |
| Reserves | 13 | €74,092,524 | €74,092,524 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,143,360 | €1,143,360 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,087,514 | €1,087,514 | = | 0.0% |
| Other | 1319 | €55,846 | €55,846 | = | 0.0% |
| Tax-exempt reserves | 132 | €13,161,686 | €13,161,686 | = | 0.0% |
| Distributable reserves | 133 | €59,787,478 | €59,787,478 | = | 0.0% |
| Profit (loss) carried forward | 14 | €47,685,714 | €46,140,599 | -€1.5m | -3.2% |
| Amounts payable | 17/49 | €522,997 | €1,344,138 | +€821,141 | +157.0% |
| Amounts payable within one year | 42/48 | €522,997 | €1,344,138 | +€821,141 | +157.0% |
| Trade debts | 44 | €3,750 | €28,585 | +€24,835 | +662.3% |
| Suppliers | 440/4 | €3,750 | €28,585 | +€24,835 | +662.3% |
| Other amounts payable | 47/48 | €519,247 | €1,315,553 | +€796,306 | +153.4% |
| Operating income | 70/76A | €239,174 | - | -€239,174 | |
| Other operating income | 74 | €602 | - | -€602 | |
| Non-recurring operating income | 76A | €238,572 | - | -€238,572 | |
| Operating charges | 60/66A | €410,739 | €355,931 | -€54,808 | -13.3% |
| Services and other goods | 61 | €201,768 | €333,152 | +€131,384 | +65.1% |
| Other operating charges | 640/8 | €19,030 | €22,779 | +€3,749 | +19.7% |
| Non-recurring operating charges | 66A | €189,941 | - | -€189,941 | |
| Operating profit (loss) | 9901 | -€171,565 | -€355,931 | -€184,366 | -107.5% |
| Financial income | 75/76B | €111,785 | €121,151 | +€9,366 | +8.4% |
| Recurring financial income | 75 | €105,175 | €120,245 | +€15,070 | +14.3% |
| Income from financial fixed assets | 750 | €105,175 | €103,598 | -€1,577 | -1.5% |
| Income from current assets | 751 | - | €16,647 | +€16,647 | |
| Non-recurring financial income | 76B | €6,610 | €906 | -€5,704 | -86.3% |
| Financial charges | 65/66B | €2,430 | €2,340 | -€90 | -3.7% |
| Recurring financial charges | 65 | €2,430 | €2,340 | -€90 | -3.7% |
| Other financial charges | 652/9 | €2,430 | €2,340 | -€90 | -3.7% |
| Profit (loss) for the period before taxes | 9903 | -€62,210 | -€237,120 | -€174,910 | -281.2% |
| Income taxes | 67/77 | -€2,153 | €4,994 | +€7,147 | |
| Taxes | 670/3 | - | €4,994 | +€4,994 | |
| Tax adjustments and reversals of tax provisions | 77 | €2,153 | - | -€2,153 | |
| Profit (loss) for the period | 9904 | -€60,057 | -€242,114 | -€182,057 | -303.1% |
| Profit (loss) for the period to be appropriated | 9905 | -€60,057 | -€242,114 | -€182,057 | -303.1% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.